Schizophrenia

Schizophrenia is a chronic mental health disorder that causes people to think, feel and perceive the world differently to the general population. It is characterized by episodes of psychosis, usually with hallucinations or delusions.

Latest Schizophrenia News and Research

Assigning patients to five well defined subgroups of psychoses

Psychiatrists led by Nikolaos Koutsouleris from Ludwig-Maximilians-Universitaet in Munich have used a computer-based approach to assign psychotic patients diagnosed as bipolar or schizophrenic to five different subgroups. The method could lead to better therapies for psychoses.

25 Feb 2020

Understanding how juvenile social isolation might shape long term behavioral outcomes

Mount Sinai Researchers find social isolation during key developmental windows drives long term changes to activity patterns of neurons involved in initiating social approach in an animal model.

22 Feb 2020

Brain activity can reveal empathy

Empathy is the ability to understand and share the feelings of other people. Is it possible to detect a person's empathy through brain activity?

19 Feb 2020

Research shows how Ebola virus interacts with human lipids

Robert Stahelin studies some of the world's deadliest viruses. Filoviruses, including Ebola virus and Marburg virus, cause viral hemorrhagic fever with high fatality rates.

16 Feb 2020

Researchers identify key modifier in large genetic deletion linked to neurodevelopmental disorders

Neurodevelopmental disorders, including schizophrenia and autism, likely result from complex interactions that modify the effects of individual genes.

16 Feb 2020

Scientists unravel mechanisms that lead to ventricular enlargement in schizophrenia

Enlarged cerebral ventricles are found in 80% of individuals with schizophrenia, yet the mechanisms that lead to ventricular enlargement are mostly unknown.

14 Feb 2020

Improving ability to predict autism risk with few drops of blood

Within days of birth, a few drops of blood are collected from every newborn in California--and across the United States -- which are then stored on filter paper and screened for dozens of genetic and congenital disorders, such as phenylketonuria, an inherited metabolic disorder that can result in intellectual disability, seizures, heart and behavioral problems.

13 Feb 2020

New study provides clear picture of brain abnormalities associated with schizophrenia

What if the key to a better understanding of schizophrenia has been here all along--but researchers haven't had the resources to study it?

12 Feb 2020

Study sheds new light on genetic relationship between three mood disorders

Researchers shed new light on the genetic relationship between three mood disorders associated with depression--major depression and bipolar disorder types 1 and 2, in a new study in the journal Biological Psychiatry, published by Elsevier.

5 Feb 2020

People with ASD have cellular abnormality that impairs myelin production, study reveals

People with autism spectrum disorder appear to suffer malfunctions in a cell that produces a special coating around nerve fibers that facilitates efficient electrical communication across the brain.

4 Feb 2020

Flickering light triggers the brain to release signaling chemicals that may help fight Alzheimer's

For over a century, Alzheimer's disease has confounded all attempts to treat it. But in recent years, perplexing experiments using flickering light have shown promise.

4 Feb 2020

Brain imaging has limited applicability in evaluating defendant's sanity

Sophisticated brain imaging, like an MRI, has limited applicability in assessing a defendant's sanity, investigators say.

3 Feb 2020

Safer and more affordable medicine for all? How Pharmacogenomics may level the playing field

Pharmacogenomics – a new scientific research field focused on the interplay between the human genome and the safety and efficacy of modern drugs, may level the playing field for all patients.

From OHAUS Corporation 31 Jan 2020

Researchers examine abnormal neuron activity in Rett syndrome

The brain undergoes dramatic change during the first years of life. Its circuits readily rewire as an infant and then child encounters new sights and sounds, taking in the world and learning to understand it. As the child matures and key developmental periods pass, the brain becomes less malleable--but certain experiences create opportunities for parts of the adult brain to rewire and learn again.

29 Jan 2020

Study offers significant promise for treating an aspect of schizophrenia

Research by a University of Georgia psychologist shows that targeting one particular symptom of schizophrenia has a positive effect on other symptoms, offering significant promise for treating an aspect of schizophrenia that currently has no pharmaceutical options.

28 Jan 2020

Study: Non-medical cannabis use is more common in adults suffering from pain

A new study from researchers at Columbia University Vagelos College of Physicians and Surgeons found that non-medical cannabis use--including frequent or problematic use--is significantly more common in adults with pain than in those without pain.

22 Jan 2020

FDA-approved medication for opioid addiction is increasing except in the youngest group

An analysis of national data on buprenorphine use found that treatment with the FDA-approved medication for opioid addiction is increasing in all age groups except the young (age 15-24 years), in whom use of the medication is decreasing.

21 Jan 2020

Researchers use new eye movement test to study brain aging effects

A new study, published in PeerJ, shows how University of Liverpool researchers have used a newly developed eye movement test to improve the understanding of how parts of the brain work.

16 Jan 2020

Protein SV2A levels could explain poor neuronal connections in schizophrenia

A team of researchers have found that persons with schizophrenia may have lower levels of certain specific proteins that show up on their brain scans. This could help as diagnostic tools, say experts. The new study titled, “Synaptic density marker SV2A is reduced in schizophrenia patients and unaffected by antipsychotics in rats”, is published in the latest issue of the journal Nature Communications.

14 Jan 2020

Overactivation of neuroimmune gene leads to schizophrenia-like changes in mice

Excessive activity of an immune system gene previously linked to schizophrenia reproduces neural and behavioral aspects of the disease in mice, according to a new study publishing on January 14 in the open-access journal PLOS Biology by Ashley Comer and Alberto Cruz-Martín of Boston University and colleagues.

14 Jan 2020